| 341 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 342 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 343 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 344 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 345 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 346 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 347 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 348 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 349 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
| 350 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
Do you have any questions? 
